Pacemakers will gain further traction with its use in cardiac resynchronization therapy due to the product's success rates, efficacy and longevity.

Currently, there are limited interventional cardiology and electrophysiology centres to perform cardiac rhythm implants.

"To meet the needs of the growing incidence, the Indonesian government is encouraging private hospitals and foreign participants to establish hospitals in the country," notes Srinivasan.

"As the rising wealth and population growth necessitate quality healthcare services in Indonesia, the government has decided to extend the maximum limit for foreign ownership from 47 percent to 67 percent. As a result of this legislation, more foreign hospitals with sophisticated technologies and infrastructure are expected to invest in Indonesia," says Eugene van de Weerd, Country Director, Frost & Sullivan - Indonesia. "Such a move is expected to result in more cardiac, oncological, and other surgeries taking place within the country, thereby curtailing the need for medical treatment abroad." Eugene concluded.